Results 91 to 100 of about 2,734 (105)

Transcriptome-Wide Identification of Neuropeptides and Neuropeptide Receptors in the Twenty-Eight-Spotted Ladybird <i>Henosepilachna vigintioctopunctata</i>. [PDF]

Insects
Lei Q, Wang Z, Yao S, Lin A, Zhang Y, Sun C, Liu X, Du M, Liu X, An S.   +9 more
europepmc   +1 more source

Long-Term Tolvaptan Administration in Chinese Patients with Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study in Real Clinical Practice.

Kidney Blood Press Res
Li M, Sun M, Cui S, Liu X, Guo M, Xiao Y, Huang Y, Zhou S, Wang H, Chen X, Li Q.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH)

European Journal of Clinical Pharmacology, 2011
Arginine vasopressin (AVP) is the major physiological regulator of renal water excretion and blood volume. The AVP pathways of V(1a)R-mediated vasoconstriction and V(2)R-induced water retention represent a potentially attractive target of therapy for edematous diseases.
Natig Gassanov, Nasser Semmo, Mariam Semmo   +2 more
exaly   +4 more sources

Effects of an oral vasopressin receptor antagonist (OPC‐31260) in a dog with syndrome of inappropriate secretion of antidiuretic hormone

Australian Veterinary Journal, 2000
ObjectiveThe syndrome of inappropriate secretion of antidiuretic hormone is a rare disorder in dogs characterised by hypo‐osmolality and persistent arginine vasopressin production in the absence of hypovolaemia and/or hypotension. The study describes the efficacy and safety of the nonpeptide selective arginine vasopressin V2receptor antagonist OPC ...
Peter J Irwin, L M Fleeman
exaly   +6 more sources

Vasopressin V2 receptor antagonists for the syndrome of inappropriate antidiuretic hormone secretion

International Urology and Nephrology, 2023
Masayuki Tanemoto, Tanemoto Masayuki
exaly   +3 more sources

Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1

Bioorganic and Medicinal Chemistry Letters, 2005
Kosuke Kanuma, Yoshinori Sekiguchi
exaly  

Growth hormone secretagogue receptor antagonists

Expert Opinion on Therapeutic Patents, 2012
Luca Costantino
exaly  

Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1

Bioorganic and Medicinal Chemistry Letters, 2005
Kosuke Kanuma, Yoshinori Sekiguchi
exaly  

Chlorpropamide upregulates antidiuretic hormone receptors and unmasks constitutive receptor signaling

American Journal of Physiology - Renal Physiology, 2000
J Hensen
exaly